Chargement en cours...
Ceftolozane-tazobactam for the Treatment of Multi Drug-resistant Pseudomonas aeruginosa (MDRPA) Infections
BACKGROUND: Ceftolozane-tazobactam (TOL-TAZ) is a novel cephalosporin/β-lactamase inhibitor combination with potent activity against Pseudomonas aeruginosa, including MDRPA. TOL-TAZ use for MDRPA infections has not been well-studied. METHODS: We conducted a retrospective study to describe outcomes o...
Enregistré dans:
| Publié dans: | Open Forum Infect Dis |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5632154/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx163.643 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|